BR PHARMA INTERNATIONAL LIMITED

Active Loughton

Wholesale of pharmaceutical goods

0 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
B

BR PHARMA INTERNATIONAL LIMITED

Wholesale of pharmaceutical goods

Founded 1 Jul 1998 Active Loughton, United Kingdom 0 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 31 Mar 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 1 Jul 2025 Next due 15 Jul 2026 2 months remaining
Net assets £6K £0 2025 year on year
Total assets £6K £0 2025 year on year
Total Liabilities £0
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Haslers Old Station Road Loughton Essex IG10 4PL

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BR PHARMA INTERNATIONAL LIMITED (03591021), an active life sciences and medical technology company based in Loughton, United Kingdom. Incorporated 1 Jul 1998. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2014–2025)

Cash in Bank

N/A

Net Assets

£5.65k

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (4)

Teleta Pharma Holdings Limited
98.3%
561,889
Teleta Pharma Holdings Limited
0.8%
4,375

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 22 May 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Fabienne Rabin

Ceased 22 May 2019

Ceased

Joel Rabin

Ceased 22 May 2019

Ceased

Rebecca Eleanor Blinston-jones

Ceased 22 May 2019

Ceased

Group Structure

Group Structure

BR PHARMA INTERNATIONAL LIMITED Current Company
CD PHARMA LIMITED united kingdom

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
1 Jul 2025Confirmation StatementConfirmation statement made on 1 Jul 2025 with updates
31 Mar 2025AccountsAnnual accounts made up to 30 Jun 2024
12 Jul 2024Confirmation StatementConfirmation statement made on 1 Jul 2024 with updates
11 Jul 2024OfficersChange to director Sheryl Anne Glanvill on 11 Jul 2024
31 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

1 Jul 2025 Confirmation Statement

Confirmation statement made on 1 Jul 2025 with updates

31 Mar 2025 Accounts

Annual accounts made up to 30 Jun 2024

12 Jul 2024 Confirmation Statement

Confirmation statement made on 1 Jul 2024 with updates

11 Jul 2024 Officers

Change to director Sheryl Anne Glanvill on 11 Jul 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 31 Mar 2026

Confirmation statement made on 1 Jul 2025 with updates

10 months ago on 1 Jul 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 31 Mar 2025

Confirmation statement made on 1 Jul 2024 with updates

1 years ago on 12 Jul 2024

Change to director Sheryl Anne Glanvill on 11 Jul 2024

1 years ago on 11 Jul 2024